Optiver Holding
AURA icon

Optiver Holding’s Aura Biosciences AURA Stock Holding History

Optiver Holding’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04K Sell
288
-104
-27% -$744 ﹤0.01% 2303
2026
Q1 		$2.62K Sell
392
-192
-33% -$1.1K ﹤0.01% 1740
2025
Q4 		$3.18K Buy
+584
New +$3.47K ﹤0.01% 1715

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Optiver Holding's AURA Position: Q2 2026 in Review

Optiver Holding reduced its Aura Biosciences (AURA) stake by 27% in Q2 2026, selling an estimated $744 and leaving 288 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2303.

Optiver Holding first reported a position in AURA in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.18K in Q4 2025. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Optiver Holding held 288 shares of Aura Biosciences worth $2.04K as of Q2 2026.
  • Optiver Holding sold 104 Aura Biosciences shares in Q2 2026, an estimated $744.
  • Aura Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2303 holding.
  • Optiver Holding first reported a position in Aura Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Optiver Holding's Aura Biosciences position peaked at $3.18K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.